ArticlePloS one2020
NIH funding trends to US medical schools from 2009 to 2018.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Educational-representational alignment among MD/MBA graduates in US Senior Academic Medical Leadership: a cross-sectional study.BMC medical education · 2026Article
- A case study on barriers to the research implementation of a novel technology in an academic medical center.PLOS digital health · 2025Article
- PubMed-Indexed Productivity of Matched Orthopedic Surgery Applicants Before and After Step 1 Scoring Transition.Cureus · 2025Article
- Review
- Article
- Using focused ethnography to inform biomedical research infrastructure enhancement at primarily undergraduate institutions.Advances in physiology education · 2024Review
- A Primer on BRIMR: Understanding the Rankings of NIH Support from the Blue Ridge Institute for Medical Research.The American journal of pathology · 2022Article
- An Analysis of the Diversity and Inclusion Content Featured on Ophthalmology Residency Program Web Sites.Journal of academic ophthalmology (2017) · 2022Article
- Dynamics of cumulative advantage and threats to equity in open science: a scoping review.Royal Society open science · 2022Article
- Article
- A Step in the Right Direction for Surgeon-Scientists.Journal of the American College of Surgeons · 2021Article
- Current Issues on Research Conducted to Improve Women's Health.Healthcare (Basel, Switzerland) · 2021Article
- Downstream funding success of early career researchers for resubmitted versus new applications: A matched cohort.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Total NIH funding dollars have increased from 2009-2018. We questioned whether this growth has occurred proportionately around the country and throughout allopathic medical schools. Therefore, we compared the trend in NIH grant funding from 2009 to 2018 for United States allopathic medical schools among historically top-funded schools, private and public schools, and by region of the country. Changes in both unadjusted and real funding dollars over time revealed a significant difference. Region was the only significant factor for mean percent change in funding from 2009-2018, with the Western region showing a 33.79% increase in purchasing power. The Northeastern region showed a -6.64% decrease in purchasing power while the Central and Southern regions reported changes of 2.46% and -6.08%, respectively. The mean percent increases were more proportional and nonsignificant in the public vs. private institutions comparison, at -3.41% and 4.75%, respectively. Likewise, the top-funded institutions vs. other institutions comparisons demonstrated modest, nonsignificant differences. However, although the relative changes might be proportional, the absolute increases evidence a pattern of growing cumulative advantage that favor the highest-funded institutions and private institutions. The potential consequences of this disproportionate increase include health science education, biomedical research, and patient access disparities in large parts of the country. The NIH and the scientific community should explore potential solutions in its funding models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.